ASTRO-ARRO Meet Me in Treatment Planning Genitourinary with Dr. Seungtaek Choi

June 26, 2018

This resident's webinar will discuss treatment planning for genitourinary cancer cases. Radiation oncology residents consistently report that plan evaluation is an aspect of residency training that is lacking. During this webinar, Dr. Seungtaek Choi an expert in genitourinary cancers, will lead residents through the key components of plan evaluation.  Please join us on Tuesday, June 26, 2018 5:00 p.m. – 6:00 p.m. Eastern Daylight Time.

This webinar is sponsored by the ROI Juan A. del Regato Fund. 

Target Audience

This program is designed to meet the interest of radiation oncology residents.

Learning Objectives

  • Demonstrate the key components of treatment planning for genitourinary cases. 
Course summary
Available credit: 
  • 1.00 Certificate of Attendance
    This activity was designated for 0.00 AMA PRA Category 1 Credit™.
Course opens: 
Course expires: 
Event starts: 
06/26/2018 - 5:00pm EDT
Event ends: 
06/26/2018 - 7:00pm EDT

Seungtaek Choi, MD has no financial relationships with a commercial interest.

Available Credit

  • 1.00 Certificate of Attendance
    This activity was designated for 0.00 AMA PRA Category 1 Credit™.


Please login or register to take this course.

Course Fees:
This webinar is free to residents.

No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.


Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.